the foundation for collaborative medicine and research

What the foundation for collaborative medicine and research does

The Foundation for Collaborative Medicine and Research (CollMed) is a 501(c)(3) non-profit research institute headquartered at PO Box 16, Rowayton, Connecticut, that conducts integrative oncology research and provides private medical consultations led by Professor Dr. Dana F. Flavin. The organization investigates nutrition, nutrient supplements, off-label drug protocols (including Metformin, Low-dose Naltrexone, Dichloroacetate, Cimetidine, Mebendazole, and Boswellia), and detoxification methodologies as adjuncts or alternatives to conventional cancer treatment, with active research programs targeting breast cancer metastases reversal, leukemia, multiple sclerosis, ALS, and immune suppression. Dr. Flavin holds medical licenses in Germany (#310011) and Ireland (#422036) plus a German naturopathic license, and collaborates with a network of professionals across Germany, Austria, Italy, and the United States.

CollMed's core service offerings include one-on-one patient consultations scheduled through the website, peer-reviewed publications, and an extensive content platform comprising a 71-page blog, video interviews with health-focused media personalities, and downloadable white papers. The organization explicitly maintains no financial affiliations with pharmaceutical or profit-making companies, positioning its independence as a key differentiator from foundations that conduct product-supporting research. Patient testimonials document individual case outcomes including reversal of Stage IV skin cancer, ductal carcinoma, Stage 4 lung cancer with brain and bone metastases, and a 97% reduction in CA125 tumor markers in ovarian cancer.

The business model is donation-driven: as a registered 501(c)(3), CollMed relies entirely on contributions from the public, with donors able to direct funds to specific research programs (canRSBC, RSL, RSMs, RSCI). No commercial products are sold, consultation fees are not publicly disclosed, and the organization has no parent company, subsidiaries, or external ownership. The operational footprint is intentionally lean, with Dr. Flavin as the sole clinical practitioner and Denise J. coordinating consultation logistics. HIPAA-compliant privacy practices are documented, and the patient base consists exclusively of individual cancer patients and health-conscious individuals seeking alternative or integrative care.

Name

the foundation for collaborative medicine and research

Legal name

The Foundation for Collaborative Medicine and Research, Inc.

Website

https://collmed.org

Company type

Private

Operating status

Operating

Short description

CollMed is a 501(c)(3) non-profit research institute that conducts integrative oncology research and provides private cancer consultations led by Dr. Dana F. Flavin, serving individual patients globally through a donation-funded model with no pharmaceutical affiliations.

Ownership category

akta.pro rank

Product category

Integrative Oncology Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Integrative oncology research
• Alternative cancer treatment
• Holistic cancer therapy
• Biochemical pharmacology research
• Cancer reversal protocols

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Donations and Contributions: As a 501(c)(3) non-profit organization, CollMed relies entirely on donations and contributions from the public. Donations may be general or specific to particular areas of research interest. All donations are tax deductible.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

CollMed is a 501(c)(3) non-profit research institute that conducts integrative oncology research and provides private medical consultations with Dr. Dana F. Flavin. The organization combines conventional, complementary, and alternative medicine approaches — including nutrition, nutrient supplements, and off-label drugs — to address cancer treatment, reversal, and prevention, while publishing research, educational blog content, and video interviews.

Product overview

The Foundation for Collaborative Medicine and Research (CollMed) is a 501(c)(3) non-profit research institute led by Dr. Dana F. Flavin, offering a portfolio of services centered on cancer research and alternative treatment approaches. The core offerings include private medical consultations providing personalized cancer treatment protocols combining conventional and complementary medicine, published research on nutrition, nutrient supplements, and off-label drugs, and educational content through an extensive blog and video interview platform. The organization focuses on finding innovative solutions for cancer prevention and alternative cancer treatments, operating without affiliation to profit-driven companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Consultation Services Private medical consultations with Dr. Dana F. Flavin providing personalized cancer treatment approaches combining conventional, complementary, and alternative medicine methodologies for individual patients seeking alternative cancer care.
• Cancer Research and Publications Research on nutrition, nutrient supplements, and off-label drugs for decreasing cancer risks and supporting alternative cancer solutions, with published papers in journals including the New Zealand Medical Journal, Journal of Orthomolecular Medicine, and Journal of Oncology.
• Health Blog and Educational Content Educational blog covering cancer therapy, detoxification, diet and nutrition, viral infections, parasites, and holistic healing approaches written by Dr. Dana Flavin to share research findings with the public.
• Video Interviews Video content featuring Dr. Dana F. Flavin discussing cancer research, treatment approaches, and interviews with media personalities on integrative health topics.

Quantifiable outcome

• Stage IV skin cancer metastases eliminated with diet, infusions, supplements and detoxification plan
• +5 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Regional players

• Cancer Research UK: A major nonprofit funder and communicator of cancer research with extensive public education and scientific activity. It is a regional research peer to CollMed's medical research and cancer-awareness activities.

Emerging players

• Chopra Global: A consumer-facing integrative health education and coaching platform covering mind-body medicine, nutrition, and wellness. It is an emerging peer to CollMed's educational content and direct patient-engagement model, with less oncology specialization.
• Bastyr University: An academic institution focused on natural health sciences, integrative medicine, and clinician education. It is an emerging adjacent peer through its health education and research orientation, though it is not cancer-specific.

Direct peers

• The Gerson Institute: A nonprofit that promotes and teaches the Gerson approach, an alternative cancer-therapy system, through education and practitioner resources. It is directly comparable to CollMed's alternative oncology research and educational mission.
• Cancer Research Institute: A nonprofit cancer research organization focused on immunotherapy and tumor immunology, funding and communicating research advances. It is a direct peer in cancer research and patient or advocacy communication, although it does not provide CollMed's individualized consultations.
• Ralph Moss Reports: An independent cancer-treatment research and consulting service that helps patients evaluate conventional and non-conventional options. It is a direct peer to CollMed's research-led consultations and patient-facing educational content.

Broad incumbents

• Mayo Clinic: An integrated health system with cancer research, multidisciplinary care, and patient education. It is a broad incumbent peer to CollMed's integrative health consultations and research dissemination.
• City of Hope: A major cancer research and treatment organization with comprehensive oncology programs and established patient-care infrastructure. It is a broad incumbent comparable to CollMed's cancer research and direct-to-patient mission, but with substantially greater institutional scale.
• Memorial Sloan Kettering Cancer Center: An integrated cancer research and treatment center combining laboratory research, clinical care, and patient education. It is a broad incumbent peer for CollMed's oncology research and consultation offering.
• MD Anderson Cancer Center: A large academic cancer center with extensive research, treatment, and education programs. It is a broad incumbent peer because it addresses the same cancer patients and research and education needs as CollMed.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/DrDanaFlavin
• Facebookfacebook.com/DrDanaFlavin
• LinkedInlinkedin.com/company/foundation-for-collaborative-medicine-and-research

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about the foundation for collaborative medicine and research